An innovative theranostic approach to TBI drub development: TBI biomarkers-guided novel calpain protease inhibito as neuroprotectant with druggable
Ended Cooperative Agreement Awarded Last action
- Award ID
- W81XWH1120002
- Recipient
-
Banyan Biomarkers, Inc. UEI UXMCAUMK9MP7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $4,755,251
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Funding agency
- Department of Defense
- Place of performance
- Florida, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$3 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $853,724 | |
| Amendment | $951,000 | |
| Amendment | $99,000 | |
| Amendment | $950,510 | |
| Amendment | $950,510 | |
| Original award | $950,510 |
Quick answers
Who received award W81XWH1120002?
W81XWH1120002 was awarded to Banyan Biomarkers, Inc. by Medical Command (Department of the Army) on October 1, 2010.
How much is award W81XWH1120002 worth?
$4,755,251 has been obligated on W81XWH1120002.
Which agency awarded W81XWH1120002?
Medical Command (Department of the Army) awarded W81XWH1120002, with funding from Department of Defense.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award